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Summary. The actions of the phosphodiesterase inhibitor 
denbufylline on the excitability of hippocampal neurons 
were investigated by means of extracellular and intra- 
cellular recordings. Denbufylline, which has been shown 
to selectively inhibit a low KM, Ca/+/calmodulin-inde - 
pendent phosphodiesterase i ozyme, concentration-de- 
pendently increased the amplitude of the extracellularly 
recorded CA1 population spike evoked by electrical 
stimulation of the Schaffer collateral/commissural p th- 
way. Concentration-response-curves yielded an ECso 
for denbufylline of 0.76 pM. In comparison, the non- 
selective phosphodiesterase inhibitor 3-isobutyl-1- 
methylxanthine (IBMX) also produced an increase 
in the amplitude of the population spike. From the 
concentration-response-curve, which was steeper than 
that of denbufylline, an ECso for IBMX of 1.04 gM 
was obtained. However, despite their similar ECso 
values, denbufylline was found to be significantly more 
potent at lower concentrations (<300nM) than 
IBMX. 
Intracellular recordings from CA1 pyramidal cells re- 
vealed postsynaptic actions of denbufylline (300 nM) as 
indicated by a small drug-induced depolarization 
(2 - 5 mV) associated with an increase in membrane input 
resistance by 10-  20%. In addition, denbufylline blocked 
the accommodation f trains of action potentials evoked 
by the injection of depolarizing current pulses. 
The results suggest i) that accumulation ofadenosine- 
3',Y-monophosphate (cAMP) in the postsynaptic cell 
and/or in the presynaptic terminal produced by blockade 
of phosphodiesterases leads to enhanced synaptic trans- 
mission in the CA1 area of the hippocampus and ii) 
that a low Ku, Ca2+/calmodulin-independent cAMP- 
phosphodiesterase is an important component involved 
in the regulation of the intracellular cAMP level at syn- 
apses of central nervous ystem neurons. 
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Introduction 
Phosphodiesterases represent a family of several isozymes 
which are responsible for the inactivation of the intra- 
cellular second messenger adenosine-Y,5'-monophos- 
phate (cAMP) (Beavo 1988). In the cerebral cortex, at 
least three different isozymes exist. One of them is the 
so-called low KM, Ca 2 ÷/calmodulin-independent cAMP- 
phosphodiesterase (Thompson and Appleman 1971; 
Strada et al. 1984; Nicholson and Wilke 1987). This 
isozyme is characterized by a high affinity for cAMP 
(KM = 2 gM) and a low affinity for cyclic guanosine-Y,5'- 
monophosphate (cGMP, KM ---- 310 gM). Furthermore, 
at low concentrations, cGMP does not inhibit the activity 
of this phosphodiesterase isozyme (Kx = 530 gM, Beavo 
1988). The low KM, Ca2+/calmodulin-independent 
cAMP-phosphodiesterase is responsible for about 20-  
30% of total phosphodiesterase activity in brain tissue 
(Strada et al. 1984, Nicholson and Wilke 1987). 
Many neurotransmitters modulate the activity of cen- 
tral nervous ystem neurons via changes in the intracellu- 
lar concentration fthe second messenger cAMP (Siggins 
and Gruol 1986). It might therefore be expected that 
the selective blockade of a phosphodiesterase i ozyme 
involved in the termination of the action of the second 
messenger should lead to changes in neuronal excitability. 
The alkylxanthine derivative denbufylline (1,3-di-n- 
butyl-7-(2'-oxopropyl)-xanthine) is a substance which 
has been shown to enhance oxygen- and glucose-con- 
sumption in animal models of cerebrovascular disease 
(Nicholson et al. 1987). During acute experimental is- 
chemia, this compound increases the p02 in the cerebral 
cortex and prevents or retards the development of brain 
edema (Nicholson and Angersbach 1986). Furthermore, 
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denbufylline improves performance of animals during 
behavioral tests (Nicholson et al. 1988), enhances the 
pO2 and function of partially ischemic skeletal muscle 
(Angersbach and Ochlich 1984), and decreases blood vis- 
cosity (Jukna and Nicholson 1987). In clinical studies, 
denbufylline was effective in the therapy of multi-infarct 
dementia (O'Connolly et al. 1986). 
This broad spectrum of activity of denbufylline is 
most probably due to a pronounced inhibition of 
phosphodiesterase activity in brain, skeletal muscle and 
erythrocytes (Nicholson and Wilke 1986). Biochemical 
studies on partially purified isozymes derived from rat 
cerebral cortex revealed that denbufylline selectively 
blocks a low KM, Ca 2 +/calmodulin-independent cAMP- 
phosphodiesterase, theK1 being 0.7 ~tM (Nicholson et al. 
1989). 
In the present study, denbufylline was used to investi- 
gate the involvement of a low KM, Ca 2 +/calmodulin- 
independent cAMP-phosphodiesterase in the modulation 
of synaptic transmission in the CA1 area of guinea pig 
hippocampus. 
Methods 
Guinea pigs (200- 300 g) were anesthetized with ether and decapi- 
tated. The brain was quickly removed an  chilled in ice-cold artificial 
cerebrospinal fluid (ACSF). Following isolation f the hippocampus 
from each hemisphere, transverse slices (500 gin) were prepar d 
using a vibratome (Vibroslice, Campden I struments, London, UK) 
and stored in ACSF at room temperature for about 1 h. The slices 
were transferred to the recording chamber where they were kept 
submerged in ACSF consisting of (in raM): NaC1 118, KC1 3, 
NaH2PO4 1.2, CaCI2 2, MgC12 1,3, D-glucose 11, NaHCO3 25. The 
solution was continuously gassed with a mixture of 95% Oz and 
5 % CO2 in order to obtain a pH value of 7.4 at a recording tempera- 
ture of 31 - 32 ° C. 
Extracellular recordings of timulus-evoked population spikes 
in stratum pyramidale of area CA1 were made using glass 
microelectrodes filled with 4 M NaCI (electrode resistance 2 -5  
MOhms). For stimulation, a concentric bipolar stainless steel elec- 
trode (Rhodes Instruments) was positioned into the Schaffer 
collateral/commissural pathway. Stimulation was performed using 
pulses of 100-300 ~ts in duration delivered at a frequency of 
0.05 Hz. Stimulus intensities ranged between 50 and 150 ~tA. Drug 
effects were investigated on population spikes evoked using half- 
maximal stimulus strength (half-maximal intensity = ( /max- - Imin) /  
2 + lmi,, where I,~i, is the intensity just subthreshold for the elici- 
tation of a response and/max is the intensity producing a maximum 
amplitude). 
The extracellular signals were recorded an  amplified by means 
of an Axoclamp 2 amplifier (Axon Instruments, Burlingame, CA, 
USA), averaged on-line (4- 5 subsequent sweeps), and stored using 
a laboratory computer system (CED 1401, Cambridge Instruments, 
UK, in conjunction with a Tandon PCA 40). Hard copies of the 
digitized ata were made using a HP 7470A plotter. 
Intracellular recordings from pyramidal cells of area CA1 were 
obtained by means of glass microelectrodes filled with 3 M KC1 
(electrode resistance 50-90 MOhms). For amplification of the sig- 
nals, an npi SEC 1L amplifier (npi, Tamm, FRG) was used. The 
membrane potential and the input resistance (determined by i jec- 
tion ofhyperpolarizing current pulses of 0.2 or 0.3 nA at a frequency 
of 0.1 or 0.2 Hz) were continuously monitored on a chart recorder 
(Gould System Instruments, Cleveland, OH, USA). Action poten- 
tials and signals obtained during the measurements of current-volt- 
age-relationships were digitized on-line a d stored using the labora- 
tory computer system mentioned above. 
Denbufylline and 3-isobutyl-l-methylxanthine (IBMX) were ap- 
plied by addition to the bathing solution. The drugs were dissolved 
in dimethyl sulfoxide (DMSO) to give stock solutions of 10 or 
100 mM. These solutions were diluted with ACSF to reach final 
concentrations between 10 M and 10 ~tM. Depending on the 
denbufylline or IBMX concentration applied, the final DMSO con- 
centrations ranged between 0.0001% (10nM denbufylline or 
IBMX) and 0.1% (10 gM denbufytline orIBMX). In control exper- 
iments (n = 5), the effects of0.1% DMSO solutions on the amplitude 
of the population spike were tested. At this concentration, DMSO 
produced an insignificant increase in the population spike amplitude 
by 0.6 mV (control: 2.6 + 0.4 mV (mean _+ SD), 0.1% DMSO: 
3,2 +_ 0.4 mV, p = 0.058). 
Denbufylline (BRL 30892) was kindly provided by Beecham- 
Wfilfing (Gronau, FRG). IBMX was purchased from Sigma 
(Taufkirchen, FRG) and CNQX (6-cyano-7-nitroquinoxaline-2,3- 
dion) from Tocris Neuramin (UK). 
Values are given as mean + standard deviation (SD). Statistical 
evaluations were p rformed using the paired or unpaired, two- 
tailed Student's t-test. The amplitude of the population spike was 
determined from the negative p ak to a tangent drawn between the 
first and the second maximum positivities. 
Results 
The actions of denbufylline and IBMX on the population 
spike recorded in area CAI of the guinea pig hippocam- 
pus were investigated in 74 slices. In every experiment, 
the stimulus intensity necessary to produce a maximal 
population spike amplitude was determined by measur- 
ing an input-output-curve (Fig. 1 C, control). Only those 
recordings were included into he data analysis where 
electrical stimulation using maximal stimulus strength 
did not evoke a second population spike and where the 
amplitude of the population spike produced by maximal 
or half-maximal stimulation intensities was stable for a 
control period of at least 30 min. 
Effects of denbufylline 
In 51 out of 54 slices tested, denbufylline led to an 
enhancement of the amplitude of the orthodromically 
evoked population spike. Figure 1 A depicts an example 
of recordings of population spikes from one slice under 
control conditions and in the presence of increasing con- 
centrations of denbufylline. 
In order to investigate the concentration-response- 
relationship of this effect, we first determined the time 
required to attain the equilibrium level of denbufylline's 
action. In these experiments, the amplitude of the popu- 
lation spike evoked by half-maximal stimulus strength 
was monitored before, during, and 50-90  rain after the 
application of denbufylline at a single concentration. As 
shown in Fig. 1 B, a slowly developing enhancement in
the population spike amplitude was observed following 
addition of denbufylline (300 nM) to the bathing solu- 
tion. An equilibrium level was reached within 40 rain 
after the start of the denbufylline application. This 
slow time course was typical for the development of 
denbufylline's action. In all slices tested using a 
denbufylline concentration of 300nM (n= 5), the 
maximum effect was attained within 40 min, independent 
of the duration of application (20-  60 rain). Despite pro- 
longed washout of the compound in normal ACSF (up 
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Fig. 1. Action of denbufylline (DBF) on the extracellularly recorded 
CAI population spike (PS). A: Population spikes were evoked by 
electrical stimulation of the Schaffer collateral/commissural path- 
way (time of stimulation indicated by arrows). Different concen- 
trations of denbufylline were cumulatively applied. Each trace rep- 
resents the average of 4 subsequent responses. B: Time course of 
the action of denbufylline. The diagram depicts the measurements 
made in two different slices. Denbufylline was applied for 30 min 
(see bar) at the concentrations indicated and measurements of the 
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population spike amplitude were made at 5 min intervals. For the 
purpose of comparison, the population spike amplitudes were nor- 
malized with respect to control. C: Effect of increasing concen- 
trations of denbufylline on the input-output-curve. Theamplitude 
ofthe population spike was measured as a function of the stimulus 
intensity in the absence (control) and presence of various concen- 
trations of denbufylline. The data presented in this figure were 
obtained from four different slices 
to 90 min), denbufylline's action on the population spike 
amplitude was found to be apparently irreversible 
(Fig. 1 B), even in those experiments where denbufylline 
was applied at low concentrations (30-100 nM). The 
possibility that this "apparent irreversibility" was due to 
a denbufylline-independent, progressive increase in the 
population spike amplitude could be excluded, since in 
experiments where denbufylline was without effect (3 out 
of 54 slices), a stable population spike amplitude could be 
recorded over a time range of 120-150 min (see Fig. J B). 
Furthermore, when the population spike amplitude had 
reached its maximum increase following the application 
of denbufylline at concentrations between 100 nM and 
1 gM, it remained unchanged for the rest of the recording 
period (Fig. 1 B). 
The concentration-response-relationship f  denbufyl- 
line was examined by cumulative application of the drug. 
Population spikes were evoked using half-maximal stimu- 
lation intensities and increasing concentrations of 
denbufylline were applied. In order to attain a clear equi- 
librium level, each concentration was administered for 
45 rain before switching to a solution containing a higher 
denbufylline concentration. Concentration-response- 
curves in the concentration range between 30 nM and 
] 0 ~tM were obtained from 5 slices (specimen recordings 
see Fig. J A). Due to the increasing influence of DMSO 
at denbufylline concentrations larger than 10 gM, the 
concentration-response-relationship was examined only 
up to I0 ~tM denbufylline. Following normalization of 
the population spike amplitudes with respect o control, 
the resulting values of the relative changes in population 
spike amplitudes were summarized and plotted as a func- 
tion of the logarithm of the denbufylline concentration 
(Fig. 2, circles). The minimal effective concentration was 
found to be 30 nM. At this concentration, denbufylline 
led to an increase in the population spike amplitude by 
10-20%.  At lower concentrations (10 nM, n = 3), no 
detectable action of denbufylline was observed. In the 
concentration range tested (up to 10 gM), the concen- 
tration-response-curve did not reach a clear maximum. 
In order to determine an ECso value, a sigmoid curve 
was fitted to the data points using non-linear least square 
regression analysis. The resulting curve was obtained on 
the assumption that denbufylline at a concentration of 
1 nM does not produce any effect on the population spike 
amplitude. From this curve an apparent ECso of 0.76 gM 
for denbufylline's action was calculated. This apparent 
ECso is similar to the KI value of denbufylline for the low 
KM, CaZ+/calmodulin-independent cAMP-phosphodi- 
esterase (Nicholson et al. 1989). 
In a next series of experiments, we investigated the 
influence of denbufylline on the input-output-relation- 
ship of the synaptic response in hippocampal s ices. For 
this purpose, electrical stimuli of increasing intensity were 
applied and the amplitudes of the corresponding popu- 
lation spikes were measured in the absence and presence 
of various concentrations of denbufylline. The obtained 
values were plotted as a function of the stimulus intensity 
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Fig. 2. Concentration-response-curves for denbufylline (DBF) (solM 
line, error bars downwar~ and IBMX (dashed line, error bars 
upward. For each curve, data were obtained from measurements 
perfo~ed in 5 and 4 different slices, respectively. The phosphodi- 
esterase inhibitors were applied cumulatively at incr asing concen- 
trations. The amplitudes of the popMation spikes (PS) were nor- 
malized with respect to control and plotted as a function of the 
logarithm of the phosphodiestera~e inhibitor concentrations (log M 
[inhibitor]). Data points (mean ~ SD) were fitted by a sigmoid 
function and ECso values were calculated (denbufylline: r ~ = 1.00, 
slope of the curve: 0.52; IBMX: r z = 0.995, slope of the curve: 1.08). 
In cases where data points are lacking error bars, the standard 
deviation is smNler than the size of the symbol 
(Fig. ] C). The input-output-curves show that the popu- 
lation spike amplitude increased with stimulus strength 
until a maximum was attained (Fig. 1 C, control). In all 
slices tested (n = 20), denbufylline produced a concen- 
tration-dependent shift to left of the input-output-curve 
and an increase in its maximum (Fig. 1 C). 
The maximum of the input-output-curve depends, 
inter alia, mainly on two factors: 1) on the excitability 
of afferent fibers, and 2) on the electrophysiological 
properties of the postsynaptic cells. The excitability of 
the afferent fibers innervating hippocampal CA1 neurons 
(Schaffer collateral/commissural p thway) is expressed 
by the amplitude and duration of the fiber volley preced- 
ing the population spike. Under normal conditions, this 
fiber volley partially overlaps with the synaptic field po- 
tential. In order to investigate the effects of denbufylline 
on the fiber volley in isolation, postsynaptic responses 
were blocked by the application of the selective 
quisqualate/kainate-receptor antagonist 6-cyano-7- 
nitroquinoxaline-2,3-dion (CNQX, 5 gM). Under these 
conditions, the fiber volley was clearly visible (see also 
Andreasen et al. 1989). The area of the fiber volley was 
measured and the control values were averaged and nor- 
malized to 1. In the presence of CNQX, denbufylline 
(300 nM) had no effect on the area of the fiber volley. 
The mean value was found to be 1.01 __+ 0.03 (n = 3) which 
was not significantly different from 1. This finding indi- 
cates that the denbufylline-induced increase in the ampli- 
tude of the population spike and in the maximum of the 
input-output-curve, r spectively, was not due to changes 
in the excitability of afferent fibers. 
The second possibility which might influence the 
magnitude of synaptic responses, namely changes in 
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Fig. 3. Actions of denbufylline (DBF) on an intracellulary recorded 
CA] pyramidal cell. A: Effects of denbufylline on direct evoked 
discharge of action potentials. A train of action potentials was 
evoked by the injection of a depolarizing current pulse (300 ms, 
0.15 nA, top traces) in the absence (control) a d presence of 300 nM 
denbufylline. Dashed line indicates the RMP ( -  66 mV) under con- 
trol conditions. B: Effects of denbufylline on the current-voltage- 
relationship in the same cell. The current-voltage-curve was deter- 
mined as described in the text. Theconsecutive recordings were 
superimposed (spikes were truncated by digitization). In this cell, 
denbufylline (300 nM) produced a depolarization by 3 inV. During 
the determination f the current-voltage-curve in the presence of 
denbufylline, the membrane potential was manually voltage- 
clamped to -66 mV. C: current-voltage-curves showing the re- 
lationship between injected current and measured voltage deviation 
in the absence ( ircles) and presence (squares) of denbufylline 
electrophysiological properties of the postsynaptic cells, 
was investigated by means of intracellular ecordings 
from CA1 pyramidal cells. The neurons had resting 
membrane potentials >-65  mV and input resistances 
> 60 MOhms. Following application of denbufylline 
(300 nM for 30 min), a slight depolarization (2 -5  mV) 
was observed in all neurons tested (n -- 5). In the presence 
of denbufylline, all neurons displayed an enhanced dis- 
charge of spontaneous action potentials associated with 
an increase in the frequency of small spontaneous synap- 
tic potentials. The onset of the denbufylline-induced f-
fects (] 0 - 20 rain following start of application) was simi- 
lar to that observed uring extracellular recordings and 
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Fig. 4. Effects of IBMX on the CA1 population spike amplitude. A: 
population spikes were evoked at half-maximal stimulation i tensities 
and IBMX was applied cumulatively atincreasing concentrations. Ap- 
plication time of each concentration was 30 rain. Each trace is the 
average of 4 subsequent events. Arrows indicate the time of stimu- 
lation. B: Determination f input-output-curves in the absence 
(circles) and presence ofIBMX (squares: 1gM; triangles: 10 gM). 
Recordings inA and results in B were obtained from two different 
slices 
these effects were apparently irreversible within the obser- 
vation period (up to 3 h). In Fig. 3A, the actions of 
denbufylline on the direct evoked action potential dis- 
charge is shown. Under control conditions (Fig. 3 A, left- 
hand side), a depolarizing current pulse (0.15 nA, 300 ms) 
induced a train of action potentials only within the first 
150 ms of the pulse (accommodation). At a concentration 
of 300nM (Fig. 3A, right-hand side), denbufylline 
blocked this accommodation a d a spike train was ob- 
served throughout the pulse. The effect of denbufylline 
on the neurons' current-voltage-relationship was investi- 
gated by injecting a series of hyperpolarizing current 
pulses of various amplitudes and measuring the corre- 
sponding voltage deviations in the absence and presence 
of denbufylline (Fig. 3 B). The measured values were then 
plotted as a function of the current strength injected 
(Fig. 3 C). For the purpose of comparison, denbufylline- 
induced epolarizations were compensated for by injec- 
tion of hyperpolarizing direct currents. In the presence 
of denbufylline, an increase in the slope of the current- 
voltage-curve was observed in all neurons tested (n = 3, 
Fig. 3 C). However, denbufylline did not influence the 
rectifying behaviour of the membrane. A rectification 
ratio was calculated by dividing the value of the input 
resistance determined using an 0.1 nA current pulse by 
the value obtained following the injection of a 0.6 nA 
pulse. Under control conditions, the mean value of the 
cell shown in Fig. 3 was found to be 2.07, indicating 
inward rectification. Denbufylline had no effect on this 
rectification ratio (2.03). Similar results were obtained 
from another two cells. In all neurons tested, an overall 
increase in input resistance by 10-20% was observed. 
Effects of lBMX 
The actions of the non-selective phosphodiesterase in- 
hibitor IBMX were studied in 6 experiments. Qualitat- 
ively, the effects of IBMX on neuronal excitability were 
similar to those of denbufylline: upon application of 
IBMX (100 nM-  10 gM), the amplitude of the popu- 
lation spike concentration-dependently increased 
(Fig. 4A), the input-output-curve shifted to the left and 
an increase in the maximum of the input-output-curve 
was observed in all slices tested (Fig. 4 B). Furthermore, 
IBMX did not influence the amplitude and duration of 
the fiber volley. Comparable to denbufylline, the IBMX- 
induced effects developed over a period of 15-25 rain 
and were apparently irreversible following washout of the 
compound. However, there were two differences which 
distinguished the action of IBMX from that of 
denbufylline. First, at higher concentrations (> 1 ~tM), 
IBMX led to the occurrence of a second population spike 
(Fig. 4A, 3 HM) and sometimes (in 2 out of 6 slices) to 
epileptiform afterdischarges. Second, lower concen- 
trations ofIBMX (< I gM) were significantly ess potent 
than those of denbufylline. In 4 slices, the concentration- 
response-relationship for IBMX was determined using a 
similar paradigm as with denbufylline (Fig. 2, squares). 
The minimal effective IBMX concentration was found to 
be 100 nM. On the assumption that 10 nM IBMX did 
not produce any effect on the population spike amplitude, 
a sigrnoid curve was fitted to the data points. From this 
curve, an ECso of 1.04 pM for IBMX was calculated. 
The comparison f the concentration-response-curves in 
Fig. 2 reveals that 300 nM IBMX enhanced the popu- 
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lation spike amplitude by 21.9 ___ 2.1% (n = 4), whereas, 
at the same concentration, denbufylline caused an in- 
crease by 43.8 _+ 6.3% (n = 5, Fig. 2). The difference be- 
tween these mean values is significant at a level of 
p < 0.005. In the higher concentration range (> 1 gM), 
both compounds seem to be equally potent (Fig. 2). 
Discussion 
Our results demonstrate hat the alkylxanthine derivative 
denbufylline produces a considerable increase in excit- 
ability of hippocampal neurons in vitro. Denbufylline has 
been shown to be a potent blocker of cAMP-phospho- 
diesterase activity in brain (Nicholson etal. 1989). There- 
fore, the most important question is, whether the action 
of denbufylline on neuronal excitability can be ascribed 
exclusively to an increase in the intracellular cAMP con- 
centration induced by depression of phosphodiesterase 
activity. There are several experimental observations pro- 
viding indirect evidence that denbufylline acted via an 
increase in the intracellular cAMP concentration: 
1) Nicholson et al. (1989) demonstrated that denbu- 
fylline selectively blocks a phosphodiesterase i ozyme 
which was isolated from rat cerebral cortex. This isozyme 
was characterized by a high affinity for cAMP (KM: 
2 gM) and a low affinity for cGMP (KM: 50 gM). The 
activity of this isozyme was not inhibited by cGMP and 
was independent ofthe presence of Ca / ÷ and calmodulin. 
According to Beavo (1988), this isozyme can be classified 
as a low KM, Ca/+/calmodulin-independent cAMP- 
phosphodiesterase. 2)Using radiolabelled rolipram, 
which is another selective blocker of the low KM, 
Ca 2 ÷/calmodulin-independent cAMP-phosphodiester- 
ase (Davis 1984), Kaulen et al. (1989) revealed a high 
density of rolipram binding sites in the CA1 subfield of 
the rodent hippocampus. These binding sites were most 
probably identical to low KM, Ca 2 ÷/calmodulin-indepen- 
dent cAMP-phosphodiesterases. Thus, in the hippocam- 
pus, the presence of this isozyme has been indirectly dem- 
onstrated. 3) Challiss and Nicholson (1988) showed that 
denbufylline nhances both the basal and isoproterenol- 
stimulated intracellular cAMP concentration in rat 
neocortical slices. 
From this evidence, it is legitimate to assume that, 
in our experiments, denbufylline led to an increase in 
intracellular cAMP concentration i hippocampal s ices 
by blockade of a low KM, Ca 2 ÷/calmodulin-independent 
cAMP-phosphodiesterase. However, similar to all other 
alkylxanthine derivatives, denbufylline in addition binds 
to adenosine receptors and adenosine re-uptake sites 
(Nicholson et al. 1989). Therefore, it might be possible 
that denbufylline produces an increase in the population 
spike amplitude by antagonizing a purinergic inhibitory 
tonus present in hippocampal slices (Haas and Greene 
1988). This possibility can be xcluded on the basis of the 
following reasons: 1) when compared to its inhibition 
constant for the low KM, Ca / +/calmodulin-independent 
cAMP-phosphodiesterase, theK~ values of denbufylline 
at adenosine AI and A2 receptors, respectively, as well 
as the adenosine re-uptake site have been shown to be 
significantly higher (K~ for the phosphodiesterase: 
0.7 gM; K~ for A1 receptors: 20 laM; KI for A2 receptors: 
46 gM; K~ for the adenosine re-uptake site: 200 gM, 
Nicholson et al. 1989). In our study, the ECso of the 
action of denbufylline on the population spike amplitude 
was almost similar to the K~ of denbufylline for the 
phosphodiesterase isozyme (i.e. 25 times smaller than the 
KI of denbufylline at the adenosine A1 receptor) and the 
minimal effective denbufylline concentration was found 
to be 30 nM (i.e. 670 times smaller than the K~ of 
denbufylline at the adenosine A1 receptor); 2) the selec- 
tive adenosine A1 receptor antagonist 8-cyclopentyl-l,3- 
dipropyl-xanthine (DPCPX) often evokes epileptiform 
discharges in the CA1 subfield of the hippocampus ( ee 
Alzheimer et al. 1989), whereas denbufylline never prod- 
uced such discharges, even when applied at high concen- 
trations (10 gM). Taken together, the significant differ- 
ence between the effective denbufylline concentrations 
observed in our experiments and the KI values of 
denbufylline at adenosine receptors on the one hand, and 
the lack of "DPCPX-like" actions of denbufylline on the 
other hand strongly indicates that denbufylline did not 
produce its effects by antagonizing an adenosine A~ re- 
ceptor-mediated inhibitory tonus. Therefore, we conclude 
that denbufylline increased the efficacy of synaptic trans- 
mission in hippocampal slices by an intracellular accumu- 
lation of cAMP produced by a selective blockade of a 
low KM, Ca 2 ÷/calmodulin-independent cAMP-phospho- 
diesterase. 
When compared to denbufylline, the actions of the 
non-selective phosphodiesterase inhibitor IBMX were 
qualitatively similar (increase in the population spike am- 
plitude with a similar time course). The main difference 
between both phosphodiesterase inhibitors was a signifi- 
cantly greater potency of denbufylline in the lower con- 
centration range (___ 300 nM). At higher concentrations 
(_> 1 gM), both compounds were found to be equipotent 
(see Fig. 2). However, in contrast o denbufylline, we 
have to assume that the actions of IBMX on neuronal 
excitability consisted of both, a blockade of phosphodi- 
esterase activity and a disinhibitory action via blockade 
of adenosine A~ receptors. The ECso value determined 
in our experiments (1.04 gM) is very similar to the K~ 
value of IBMX at adenosine A1 receptors (1.8 gM, 
Nicholson et al. 1989) and significantly smaller than the 
KI values of IBMX at different phosphodiesterase 
isozymes (8 -26gM,  Davis 1984). Furthermore, at 
higher concentrations (_> I gM), IBMX tended to prod- 
uce epileptiform activity, ah effect which might be ex- 
plained by an antagonistic action of IBMX at adenosine 
A~ receptors (Okada and Ozawa 1980). Thus, the concen- 
tration-response-curve for IBMX shown in Fig. 2 prob- 
ably reflects a superimposition f two different effects of 
IBMX. Consequently, it is not possible to compare the 
inhibitory efficacy of denbufylline and IBMX on 
phosphodiesterase activity on the basis of the concen- 
tration-response-curves determined in our experiments. 
The time course of the development of the 
denbufylline-induced effects agreed well with results from 
biochemical studies on cortical slices (Challiss and 
Nicholson 1988), which demonstrated that maximum 
cAMP levels are achieved within 10-20 min following 
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the application of phosphodiesterase inhibitors (denbu- 
fylline and IBMX, respectively). However, in contrast o 
these investigations, the electrophysiologically deter- 
mined actions of denbufylline were found to be irrevers- 
ible within the observation period. A possible xplanation 
for this discrepancy is that the initial rise in the intracellu- 
lar cAMP concentration produced by denbufylline 
triggered a cascade of processes leading to sustained 
changes in neuronal excitability. An analogous phenome- 
non was observed in hippocampal CA3 pyramidal cells 
following application of DPCPX (Alzheimer et al. 1989). 
DPCPX induced sustained epileptiform discharges, 
which might be triggered by a transient increase in the 
intracellular cAMP concentration due to blockade of 
adenosine A1 receptors. 
From our results, it is not possible to decide, whether 
denbufylline changes ynaptic transmission i the hippo- 
campus by a presynaptic or postsynaptic mechanism. 
Intracellular recordings revealed that denbufylline 
changed the electrophysiological properties of CA1 pyr- 
amidal cells in a way similar to noradrenaline acting via 
/?l-adrenergic receptors (Madison and Nicoll 1986 a). The 
block of accommodation associated with a small de- 
polarization and an increase in input resistance, suggests 
an inhibitory effect of denbufylline on a calcium-acti- 
vated potassium conductance, which would tend to 
amplify the amplitude of synaptic responses. In fact, 
Madison and Nicoll (1986 b) demonstrated that the selec- 
tive inhibitor of a low KM, Ca 2 +/calmodulin-independent 
cAMP-phosphodiesterase, Ro 20-1724 (Beavo 1988) de- 
presses a calcium-activated potassium conductance re- 
sulting in a blockade of spike train accommodation. 
However, although we could show that denbufylline does 
not influence the excitability of afferent fibers, an action 
of denbufylline on the release of excitatory transmitters 
cannot be excluded. An increase in the intracellular 
cAMP concentration i presynaptic terminals might fa- 
cilitate transmitter elease by changing the degree of 
phosphorylation fphosphoproteins involved in this pro- 
cess (e.g. synapsin I, see Sihra et al. 1989). Those changes 
are not reflected in the amplitude of the fiber volley. 
Based on the selectivity of denbufylline for a low Ku, 
Ca 2 +/calmodulin-independent cAMP-phosphodiester- 
ase, our results suggest hat this isozyme might play an 
important role in the modulation of synaptic trans- 
mission in the hippocampus. Similar findings were 
obtained from rat neocortical slices, where denbufylline 
facilitates ynaptic transmission (Sutor et al. 1989). The 
importance of phosphodiesterases in synaptic trans- 
mission is further substantiated by two other obser- 
vations: 1) using cytochemical techniques, Florendo et 
al. (1971) demonstrated that phosphodiesterase activity 
is predominantly located in the postsynaptic density of 
rat cortical neurons; 2) following selective destruction of 
the inferior olive, a marked reduction in calmodulin- 
dependent phosphodiesterase immunoreactivity was ob- 
served in rat cerebellar Purkinje cells, suggesting a 
transsynaptic regulation of phosphodiesterase activity 
(Balaban et al. 1989). 
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